Document Detail


Frequency-specific effects of stimulation of the subthalamic area in treated Parkinson's disease patients.
MedLine Citation:
PMID:  19525877     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
It has been hypothesized that too much synchronization in the beta band in basal ganglia-cortical circuits can contribute to bradykinesia and too little can contribute to hyperkinesia. The former has been supported by experiments in patients with Parkinson's disease and chronic implantation of the subthalamic area for deep brain stimulation. Stimulation at 20 Hz in this region slows voluntary tapping when performed in patients withdrawn from their usual antiparkinsonian medication. Here, we show the converse, that stimulation of the same region at 20 Hz in patients treated with levodopa decreases the interval between taps by 8.1+/-1.8% and makes tapping more regular. We suggest that this effect is mediated through an amelioration of levodopa-induced dyskinesias during stimulation.
Authors:
Andrea A Kühn; Noa Fogelson; Patricia Dowsey Limousin; Marwan I Hariz; Andreas Kupsch; Peter Brown
Related Documents :
16149087 - Postural reactions to neck vibration in parkinson's disease.
18989347 - Clinical characteristics of pigment dispersion syndrome in chinese patients.
22531887 - Relation of interleukin-6 in rheumatoid arthritis patients to systemic bone loss and st...
15668417 - Cerebral atrophy and its relation to cognitive impairment in parkinson disease.
2360467 - Management morbidity and mortality in grade iv and v patients with aneurysmal subarachn...
19659817 - Deep vein thrombosis in stroke patients admitted to a rehabilitation unit in singapore.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Neuroreport     Volume:  20     ISSN:  1473-558X     ISO Abbreviation:  Neuroreport     Publication Date:  2009 Jul 
Date Detail:
Created Date:  2009-06-30     Completed Date:  2009-10-12     Revised Date:  2014-02-19    
Medline Journal Info:
Nlm Unique ID:  9100935     Medline TA:  Neuroreport     Country:  England    
Other Details:
Languages:  eng     Pagination:  975-8     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Analysis of Variance
Antiparkinson Agents / therapeutic use
Deep Brain Stimulation / methods*
Electrodes, Implanted
Female
Humans
Levodopa / therapeutic use
Male
Middle Aged
Parkinson Disease / drug therapy,  therapy*
Psychomotor Performance / drug effects,  physiology*
Subthalamic Nucleus / drug effects,  physiopathology*
Grant Support
ID/Acronym/Agency:
G0400617//Medical Research Council; //Medical Research Council
Chemical
Reg. No./Substance:
0/Antiparkinson Agents; 46627O600J/Levodopa

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Primary malignant amelanotic melanoma of the female genital tract: report of two cases and review of...
Next Document:  Brain protection by methylprednisolone in rats with spinal cord injury.